-
1
-
-
2942677245
-
The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management
-
DOI 10.1200/JCO.2004.10.062
-
The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR, J Clin Oncol 2004 22 11 2141 2149 10.1200/JCO.2004.10.062 15169800 (Pubitemid 41095147)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.11
, pp. 2141-2149
-
-
Cooperberg, M.R.1
Lubeck, D.P.2
Meng, M.V.3
Mehta, S.S.4
Carroll, P.R.5
-
2
-
-
84861589572
-
Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years
-
10.1016/j.eururo.2012.03.006 22445223
-
Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Bahn D, de Castro Abreu AL, Gill IS, Hung AJ, Silverman P, Gross ME, Lieskovsky G, Ukimura O, Eur Urol 2012 62 1 55 63 10.1016/j.eururo.2012.03.006 22445223
-
(2012)
Eur Urol
, vol.62
, Issue.1
, pp. 55-63
-
-
Bahn, D.1
De Castro Abreu, A.L.2
Gill, I.S.3
Hung, A.J.4
Silverman, P.5
Gross, M.E.6
Lieskovsky, G.7
Ukimura, O.8
-
3
-
-
38049078521
-
Group consensus reports from the consensus conference on focal treatment of prostatic carcinoma, celebration, Florida, February 24, 2006
-
18194711
-
Group consensus reports from the consensus conference on focal treatment of prostatic carcinoma, celebration, Florida, February 24, 2006. Bostwick DG, Waters DJ, Farley ER, Meiers I, Rukstalis D, Cavanaugh WA, Ragde H, Dineen MK, Bahn D, Scionti S, et al. Urology 2007 70 6 Suppl 42 44 18194711
-
(2007)
Urology
, vol.70
, Issue.6 SUPPL.
, pp. 42-44
-
-
Bostwick, D.G.1
Waters, D.J.2
Farley, E.R.3
Meiers, I.4
Rukstalis, D.5
Cavanaugh, W.A.6
Ragde, H.7
Dineen, M.K.8
Bahn, D.9
Scionti, S.10
-
4
-
-
57449118482
-
Evaluating localized prostate cancer and identifying candidates for focal therapy
-
19095124
-
Evaluating localized prostate cancer and identifying candidates for focal therapy. Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT, Urology 2008 72 6 Suppl 12 S24 19095124
-
(2008)
Urology
, vol.72
, Issue.6 SUPPL.
-
-
Sartor, A.O.1
Hricak, H.2
Wheeler, T.M.3
Coleman, J.4
Penson, D.F.5
Carroll, P.R.6
Rubin, M.A.7
Scardino, P.T.8
-
5
-
-
0036297668
-
Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: A new approach to preserving potency
-
DOI 10.1016/S0090-4295(02)01643-6, PII S0090429502016436
-
Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R, Urology 2002 60 1 109 114 10.1016/S0090- 4295(02)01643-6 12231064 (Pubitemid 34722957)
-
(2002)
Urology
, vol.60
, Issue.1
, pp. 109-114
-
-
Onik, G.1
Narayan, P.2
Vaughan, D.3
Dineen, M.4
Brunelle, R.5
-
6
-
-
50649088395
-
Transperineal 3D mapping biopsy of the prostate: An essential tool in selecting patients for focal prostate cancer therapy
-
10.1016/j.urolonc.2008.03.005 18774464
-
Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Onik G, Barzell W, Urol Oncol 2008 26 5 506 510 10.1016/j.urolonc.2008.03.005 18774464
-
(2008)
Urol Oncol
, vol.26
, Issue.5
, pp. 506-510
-
-
Onik, G.1
Barzell, W.2
-
7
-
-
50649085260
-
The male lumpectomy: Focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up
-
10.1016/j.urolonc.2008.03.004 18774463
-
The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J, Urol Oncol 2008 26 5 500 505 10.1016/j.urolonc.2008.03.004 18774463
-
(2008)
Urol Oncol
, vol.26
, Issue.5
, pp. 500-505
-
-
Onik, G.1
Vaughan, D.2
Lotenfoe, R.3
Dineen, M.4
Brady, J.5
-
8
-
-
34447531757
-
Short-Term Cancer Control After Primary Cryosurgical Ablation for Clinically Localized Prostate Cancer Using Third-Generation Cryotechnology
-
DOI 10.1016/j.urology.2007.03.027, PII S0090429507003731
-
Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Polascik TJ, Nosnik I, Mayes JM, Mouraviev V, Urology 2007 70 1 117 121 10.1016/j.urology.2007.03.027 17656220 (Pubitemid 47081100)
-
(2007)
Urology
, vol.70
, Issue.1
, pp. 117-121
-
-
Polascik, T.J.1
Nosnik, I.2
Mayes, J.M.3
Mouraviev, V.4
-
9
-
-
34247621188
-
Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy
-
Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy. Mouraviev V, Mayes JM, Madden JF, Sun L, Polascik TJ, Technol Cancer Res Treat 2007 6 2 91 95 17375971 (Pubitemid 46668716)
-
(2007)
Technology in Cancer Research and Treatment
, vol.6
, Issue.2
, pp. 91-95
-
-
Mouraviev, V.1
Mayes, J.M.2
Madden, J.F.3
Sun, L.4
Polascik, T.J.5
-
10
-
-
84864008031
-
Radical prostatectomy versus observation for localized prostate cancer
-
10.1056/NEJMoa1113162 22808955
-
Radical prostatectomy versus observation for localized prostate cancer. Wilt TJ, Brawer MK, Jones KM, et al. N Engl J Med 2012 367 203 213 10.1056/NEJMoa1113162 22808955
-
(2012)
N Engl J Med
, vol.367
, pp. 203-213
-
-
Wilt, T.J.1
Brawer, M.K.2
Jones, K.M.3
-
11
-
-
65549116065
-
Focal therapy for prostate cancer: Revolution or evolution?
-
10.1186/1471-2490-9-2 19386137
-
Focal therapy for prostate cancer: revolution or evolution? Turpen R, Rosser CJ, BMC Urol 2009 9 2 10.1186/1471-2490-9-2 19386137
-
(2009)
BMC Urol
, vol.9
, pp. 2
-
-
Turpen, R.1
Rosser, C.J.2
-
12
-
-
34250003745
-
Focal Cryosurgery: Encouraging Health Outcomes for Unifocal Prostate Cancer
-
DOI 10.1016/j.urology.2007.02.047, PII S0090429507002890
-
Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Lambert EH, Bolte K, Masson P, Katz AE, Urology 2007 69 6 1117 1120 10.1016/j.urology.2007.02.047 17572198 (Pubitemid 46891597)
-
(2007)
Urology
, vol.69
, Issue.6
, pp. 1117-1120
-
-
Lambert, E.H.1
Bolte, K.2
Masson, P.3
Katz, A.E.4
-
13
-
-
38049089720
-
Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: Initial results
-
18194712
-
Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Ellis DS, Manny TB, Rewcastle JC, Urology 2007 70 6 Suppl 9 15 18194712
-
(2007)
Urology
, vol.70
, Issue.6 SUPPL.
, pp. 9-15
-
-
Ellis, D.S.1
Manny, T.B.2
Rewcastle, J.C.3
-
14
-
-
77958125182
-
An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: Recommendations for follow up
-
10.1097/PPO.0b013e3181f84639 20890154
-
An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: recommendations for follow up. Truesdale MD, Cheetham PJ, Hruby GW, Wenske S, Conforto AK, Cooper AB, Katz AE, Cancer J 2010 16 5 544 549 10.1097/PPO.0b013e3181f84639 20890154
-
(2010)
Cancer J
, vol.16
, Issue.5
, pp. 544-549
-
-
Truesdale, M.D.1
Cheetham, P.J.2
Hruby, G.W.3
Wenske, S.4
Conforto, A.K.5
Cooper, A.B.6
Katz, A.E.7
-
15
-
-
84860622818
-
Focal cryotherapy for localized prostate cancer: A report from the national cryo on-line database (COLD) registry
-
10.1111/j.1464-410X.2011.10578.x 22035200
-
Focal cryotherapy for localized prostate cancer: a report from the national cryo on-line database (COLD) registry. Ward JF, Jones JS, BJU Int 2012 109 11 1648 1654 10.1111/j.1464-410X.2011.10578.x 22035200
-
(2012)
BJU Int
, vol.109
, Issue.11
, pp. 1648-1654
-
-
Ward, J.F.1
Jones, J.S.2
-
16
-
-
77956396162
-
Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program
-
10.1200/JCO.2009.25.7311 20439642
-
Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program. Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A, Feng Z, Carter HB, Walsh PC, J Clin Oncol 2010 28 17 2810 2816 10.1200/JCO.2009.25.7311 20439642
-
(2010)
J Clin Oncol
, vol.28
, Issue.17
, pp. 2810-2816
-
-
Ross, A.E.1
Loeb, S.2
Landis, P.3
Partin, A.W.4
Epstein, J.I.5
Kettermann, A.6
Feng, Z.7
Carter, H.B.8
Walsh, P.C.9
|